Expression and clinical implication of PRL-1 and PRL-3 in transitional cell carcinoma of bladder

被引:0
|
作者
Hao B. [1 ,2 ]
Liu C. [2 ]
Li H. [3 ]
机构
[1] Department of Urology, Tongji Hospital, Huazhong University of Science and Technology
[2] Zhengzhou University
[3] Zhengzhou University
来源
Frontiers of Medicine in China | 2009年 / 3卷 / 2期
关键词
Immunohistochemistry; Phosphatase of regenerating liver 1; Phosphatase of regenerating liver 3; Reverse transcription polymerase chain reaction; Transitional cell carcinoma of bladder;
D O I
10.1007/s11684-009-0036-3
中图分类号
学科分类号
摘要
The mRNA and protein expression of phosphatase of regenerating liver 1 (PRL-1) and phosphatase of regenerating liver 3 (PRL-3) in transitional cell carcinoma of bladder (BTCC) and normal epithelia of bladder was investigated, and the relationship between the BTCC and pathological changes was clarified. The expression of PRL-1 and PRL-3 mRNA was detected by using reverse transcription polymerase chain reaction (RT-PCR) in 30 cases of BTCC and 10 cases of normal bladder, and the expression of PRL-1 and PRL-3 protein was checked by using immunohistochemistry in 30 cases of BTCC and 15 cases of normal bladder. The expression levels of PRL-1 and PRL-3 mRNA and protein were higher in BTCC than those in normal bladder epithelia (P < 0.05). The increased expression of PRL-1 and PRL-3 mRNA and protein was detectable in deep invasion and metastasis of BTCC (P < 0.05). There was no correlation between the expression of PRL-1 and PRL-3 and gender, age or recurrence of BTCC (all P > 0.05). A significantly positive correlation was found between PRL-1 and PRL-3 in BTCC (P < 0.05). PRL-1 and PRL-3 are expressed consistently and may contribute to the growth, differentiation, invasion and metastasis of BTCC. © Higher Education Press and Springer-Verlag GmbH 2009.
引用
收藏
页码:197 / 203
页数:6
相关论文
共 50 条
  • [1] PRL-3 and PRL-1 promote cell migration, invasion, and metastasis
    Zeng, Q
    Dong, JM
    Guo, K
    Li, J
    Tan, HX
    Koh, V
    Pallen, CJ
    Manser, E
    Hong, W
    [J]. CANCER RESEARCH, 2003, 63 (11) : 2716 - 2722
  • [2] Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
    Radke, I.
    Goette, M.
    Kersting, C.
    Mattsson, B.
    Kiesel, L.
    Wuelfing, P.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (03) : 347 - 354
  • [3] Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
    I Radke
    M Götte
    C Kersting
    B Mattsson
    L Kiesel
    P Wülfing
    [J]. British Journal of Cancer, 2006, 95 : 347 - 354
  • [4] Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1
    Zeng, Q
    Hong, WJ
    Tan, YH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (02) : 421 - 427
  • [5] Generation of PRL-3 and PRL-1 specific monoclonal antibodies as potential diagnostic markers for cancer metastases
    Li, J.
    Guo, K.
    Zeng, Q.
    [J]. MECHANISMS OF DEVELOPMENT, 2005, 122 : S106 - S106
  • [6] PRL-3 expression in cancer
    Gao, Xiang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (07) : 423 - 423
  • [7] PRL-3 expression in metastatic cancers
    Bardelli, A
    Saha, S
    Sager, JA
    Romans, KE
    Xin, BZ
    Markowitz, SD
    Lengauer, C
    Velculescu, VE
    Kinzler, KW
    Vogelstein, B
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (15) : 5607 - 5615
  • [8] Clinical significance of PRL-3 genomic amplification/expression profiles and preclinical study of PRL-3 inhibitor in human gastrointestinal cancers
    Yamashita, Keishi
    Watanabe, Masahiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
    Ooki, Akira
    Yamashita, Keishi
    Kikuchi, Shiro
    Sakuramoto, Shinichi
    Katada, Natsuya
    Waraya, Mina
    Kawamata, Hiroshi
    Nishimiya, Hiroshi
    Nakamura, Kazunori
    Watanabe, Masahiko
    [J]. BMC CANCER, 2011, 11
  • [10] Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
    Akira Ooki
    Keishi Yamashita
    Shiro Kikuchi
    Shinichi Sakuramoto
    Natsuya Katada
    Mina Waraya
    Hiroshi Kawamata
    Hiroshi Nishimiya
    Kazunori Nakamura
    Masahiko Watanabe
    [J]. BMC Cancer, 11